The Pharma industry is up 2.0% in the last week, with Clarity Pharmaceuticals up 9.7%. During this same period, the Neuren Pharmaceuticals underperformed, falling 6.4%. This takes the industry's 12 month performance to a gain of 62%. Earnings are forecast to grow by 38% annually.
Has the Australian Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 26 Jul 2024 | AU$6.8b | AU$995.3m | -AU$387,920,108.00 | 11.6x | -17.5x | 6.8x |
Sun, 23 Jun 2024 | AU$6.1b | AU$995.3m | -AU$387,920,108.00 | 11.8x | -15.7x | 6.1x |
Tue, 21 May 2024 | AU$6.3b | AU$1.2b | -AU$374,923,684.00 | 13.3x | -16.7x | 5.1x |
Thu, 18 Apr 2024 | AU$5.6b | AU$1.2b | -AU$374,923,684.00 | 14.9x | -14.9x | 4.6x |
Sat, 16 Mar 2024 | AU$5.5b | AU$1.2b | -AU$380,850,666.00 | 14.6x | -14.5x | 4.5x |
Mon, 12 Feb 2024 | AU$5.6b | AU$892.7m | -AU$536,464,511.00 | 20.7x | -10.5x | 6.3x |
Wed, 10 Jan 2024 | AU$5.7b | AU$896.3m | -AU$589,604,392.00 | 21.3x | -9.6x | 6.3x |
Fri, 08 Dec 2023 | AU$4.3b | AU$896.3m | -AU$589,604,392.00 | 17.5x | -7.4x | 4.8x |
Sun, 05 Nov 2023 | AU$3.7b | AU$893.0m | -AU$595,020,018.00 | 18.5x | -6.2x | 4.1x |
Tue, 03 Oct 2023 | AU$3.5b | AU$900.3m | -AU$587,952,018.00 | 19.6x | -6x | 3.9x |
Thu, 31 Aug 2023 | AU$4.2b | AU$1.1b | -AU$601,971,667.00 | 19.4x | -6.9x | 3.8x |
Sat, 29 Jul 2023 | AU$4.2b | AU$999.0m | -AU$624,794,303.00 | 22.4x | -6.8x | 4.2x |
Mon, 26 Jun 2023 | AU$3.9b | AU$999.0m | -AU$624,794,303.00 | 21.3x | -6.2x | 3.9x |
Wed, 24 May 2023 | AU$4.2b | AU$993.2m | -AU$640,306,659.00 | 19x | -6.5x | 4.2x |
Fri, 21 Apr 2023 | AU$4.1b | AU$993.2m | -AU$641,969,868.00 | 18.2x | -6.4x | 4.2x |
Sun, 19 Mar 2023 | AU$4.1b | AU$995.9m | -AU$648,651,745.00 | 18.7x | -6.3x | 4.1x |
Tue, 14 Feb 2023 | AU$3.6b | AU$950.3m | -AU$584,061,383.00 | 17.1x | -6.2x | 3.8x |
Thu, 12 Jan 2023 | AU$4.1b | AU$948.3m | -AU$544,428,006.00 | 13.2x | -7.6x | 4.4x |
Sat, 10 Dec 2022 | AU$3.9b | AU$948.3m | -AU$544,428,005.00 | 13.1x | -7.1x | 4.1x |
Mon, 07 Nov 2022 | AU$4.2b | AU$948.3m | -AU$544,428,005.00 | 12.8x | -7.8x | 4.5x |
Wed, 05 Oct 2022 | AU$4.1b | AU$946.2m | -AU$548,400,005.00 | 12.1x | -7.4x | 4.3x |
Fri, 02 Sep 2022 | AU$3.9b | AU$937.3m | -AU$530,706,609.00 | 12.9x | -7.4x | 4.2x |
Sun, 31 Jul 2022 | AU$3.9b | AU$818.2m | -AU$353,932,589.00 | 15.3x | -11.1x | 4.8x |
Tue, 28 Jun 2022 | AU$3.2b | AU$818.2m | -AU$353,932,589.00 | 12.3x | -9.2x | 4x |
Thu, 26 May 2022 | AU$3.9b | AU$818.2m | -AU$353,932,589.00 | 15x | -11.1x | 4.8x |
Sat, 23 Apr 2022 | AU$4.2b | AU$800.9m | -AU$348,637,558.00 | 16.2x | -12x | 5.2x |
Mon, 21 Mar 2022 | AU$4.4b | AU$799.2m | -AU$341,805,125.00 | 17.2x | -12.8x | 5.5x |
Wed, 16 Feb 2022 | AU$4.6b | AU$749.0m | -AU$464,190,190.00 | 20.5x | -9.9x | 6.1x |
Fri, 14 Jan 2022 | AU$5.0b | AU$758.4m | -AU$450,516,414.00 | 21.5x | -11.2x | 6.6x |
Sun, 12 Dec 2021 | AU$4.9b | AU$758.4m | -AU$450,516,414.00 | 25.2x | -10.8x | 6.4x |
Tue, 09 Nov 2021 | AU$5.0b | AU$758.4m | -AU$447,307,205.00 | 23.7x | -11.1x | 6.5x |
Thu, 07 Oct 2021 | AU$4.7b | AU$753.7m | -AU$446,965,453.00 | 23.7x | -10.4x | 6.2x |
Sat, 04 Sep 2021 | AU$4.9b | AU$756.0m | -AU$452,225,384.00 | 22x | -10.8x | 6.4x |
Mon, 02 Aug 2021 | AU$4.2b | AU$752.8m | -AU$442,004,016.00 | 20.9x | -9.4x | 5.5x |
-9.4x
How does Australian Pharma compare with similar industries?
AU Market | -2.20% | |
Healthcare | -1.08% | |
Pharma | -1.36% | |
Pharma | -1.36% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
BOT Botanix Pharmaceuticals | AU$0.38 | 1.4% +AU$9.1m | 188.5% | PS1552.5x | |
SNT Syntara | AU$0.041 | 7.9% +AU$3.6m | -18.0% | PS2.5x | |
CAN Cann Group | AU$0.034 | 17.2% +AU$2.3m | -74.8% | PS0.7x | |
VIT Vitura Health | AU$0.093 | 2.2% +AU$1.2m | -81.4% | PE5.7x | |
ACR Acrux | AU$0.069 | 3.0% +AU$581.4k | 35.3% | PS1.8x |